GlaxoSmithKline
CCI approves GSK-Pfizer consumer healthcare JV
24 May 2019
Hindustan Unilever to merge GSK Consumer Healthcare
03 Dec 2018
The all-stock merger includes GSK CH India’s entire operations, including a consignment selling contract to distribute GSK CH India’s Over-the-Counter and Oral Health products in India
GlaxoSmithKline backs out of bidding for Pfizer’s consumer unit
23 Mar 2018
GlaxoSmithKline has pulled out of bidding for the consumer healthcare business of Pfizer, days after Reckitt Benckiser’s backed out
Emma Walmsley named Glaxo's first woman CEO
20 Sep 2016
Emma Walmsley has been named the new chief executive officer of British pharmaceutical giant GlaxoSmithKline, succeeding Sir Andrew Witty and becoming the newest female boss in the FTSE 100
European regulators approve GSK’s Strivelis therapy for children with combined immunodeficiency
01 Jun 2016
GlaxoSmithKline’s majority-owned HIV business to buy drugs from US rival Bristol-Myers Squibb
18 Dec 2015
CCI Imposes Rs64 crore fine on GlaxoSmithKline, Sanofi
06 Jun 2015
CCI order comes on a complaint by Bio-Med, which alleged that GlaxoSmithKline and Sanofi collided in the tendering for meningitis vaccines in contravention of the provisions of the anti-trust Act, with passive help from the government
Novartis-GSK business deal gets CCI nod
23 Dec 2014
GSK abandons sale of older drugs portfolio
05 Dec 2014
GlaxoSmithKline's $1.57-bn restructuring to hit US jobs
04 Dec 2014
GSK is struggling with declining sales, especially in the US, mainly due to a fall in its respiratory business, which accounted for 30 per cent of its global sales last year
Ebola virus gives birth to a new vaccine
28 Nov 2014
Over the long term, GlaxoSmithKline's new vaccine is intended to protect against all Ebola outbreaks, and the drug maker hopes to produce one million doses a month of the vaccine by the end of 2015
British watchdog launches criminal probe into GSK over bribery
28 May 2014
The UK Serious Fraud Office (SFO) has launched a criminal investigation into drug giant GlaxoSmithKline (GSK) over alleged bribery in China and in other countries
GSK’s former China head charged with bribery
14 May 2014
GSK said that some of its senior Chinese executives appeared to have broken the law
Novartis AG, GSK in $23-bn assets swap deal
22 Apr 2014
Swiss drug giant Novartis AG and Britain's GlaxoSmithKline Plc (GSK) today announced a swap of assets in a deal valued at around $23 billion
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
